|
|
||||||||
Letters |
1
Department of Dermatology, University Hospital, RWTH Aachen, Pauwelsstrasse 30, 52074 Aachen, Germany
2
TIB MOLBIOL, Tempelhofer Weg 11-12, 10829 Berlin, Germany
a Address correspondence to this author at: Department of Dermatology, University Hospital RWTH Aachen, Pauwelsstrasse 30, 52074 Aachen, Germany. Fax 49-241-88-88-413; e-mail B.BLOEMEKE@RWTH-AACHEN.DE.
To the Editor:
Adverse hypersensitivity reactions to aspirin and other nonsteroidal antiinflammatory drugs (1) resemble pseudoallergic reactions with bronchospasm, chronic rhinoconjunctivitis, nasal polyps, urticaria, angioedema, life-threatening bronchospasm, and anaphylactic shock (2). Up to 25% of hospital admissions for acute asthma may be caused by nonsteroidal antiinflammatory drug ingestion. In aspirin-induced asthma, cysteine-leukotriene release into airways (3)(4) is associated with increased concentrations of leukotriene C4 synthase, the enzyme that forms leukotriene C4 [for review, see Ref. (5)]. A polymorphism in the promoter region of the gene for leukotriene C4 synthase predisposes to disease (4). The A-444C transversion creates a new MspI restriction site.
PCR-restriction fragment length polymorphism analysis has been used to
detect this
Acknowledgments
References
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |